AstraZeneca: Strategic Analysis of UK-China Joint Venture in China
VerifiedAdded on 2023/01/03
|21
|1366
|58
Presentation
AI Summary
This presentation examines the cultural challenges that AstraZeneca, a UK-based pharmaceutical company, is likely to encounter when forming a joint venture with a Chinese company. It begins by introducing the cultural differences between the UK and China, covering aspects such as greetings, communication styles, business approaches, punctuality, language barriers, and legal frameworks. The presentation then delves into the success and failure factors of joint ventures, specifically in the Chinese context. It also explores cultural sensitivity in China, including the application of Hofstede's cultural dimensions to compare UK and Chinese values. Finally, the presentation provides actionable recommendations for AstraZeneca to navigate these cultural differences, improve business communication, and ensure the success of their joint venture in China.
1 out of 21


















